General Information of Drug (ID: DMCXZ9L)

Drug Name
3-hydroxyquinazoline-2,4(1H,3H)-dione
Synonyms
3-hydroxyquinazoline-2,4(1H,3H)-dione; 3-hydroxy-quinazoline-2,4-dione; CHEMBL183852; 5329-43-1; NSC2552; AC1Q6JF3; AC1L58DP; N-hydroxy quinazolinedione, 4; SCHEMBL1520708; 3-hydroxyquinazoline-2,4-dione; CTK4J7468; BDBM33412; DTXSID00277492; ZINC1640999; NSC-2552; 3-hydroxy-1H-quinazoline-2,4-dione; 3-HYDROXY-2,3H)-QUINAZOLINEDIONE
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 178.14
Logarithm of the Partition Coefficient (xlogp) 0.1
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C8H6N2O3
IUPAC Name
3-hydroxy-1H-quinazoline-2,4-dione
Canonical SMILES
C1=CC=C2C(=C1)C(=O)N(C(=O)N2)O
InChI
InChI=1S/C8H6N2O3/c11-7-5-3-1-2-4-6(5)9-8(12)10(7)13/h1-4,13H,(H,9,12)
InChIKey
TZZSQUATPYDROZ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
220188
CAS Number
5329-43-1
TTD ID
D0NS0E

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Human immunodeficiency virus Ribonuclease H (HIV RNH) TT37KAF POL_HV1B1 Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. J Med Chem. 2009 Oct 8;52(19):5781-4.